Moreover, it is also possible that detecting increased levels of TLR6 expression in peripheral blood (see Figure 1A2) could serve as a non-invasive method to screen for patients that could potentially make progress towards more aggressive forms of obesity-related NAFLD. Here, TLR6 is linked to metabolic dysfunction-associated steatotic liver disease.